Cornberg M - Search Results

1

Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysis.

Lampertico P, Carrión JA, Curry M, Turnes J, Cornberg M, Negro F, Brown A, Persico M, Wick N, Porcalla A, Pangerl A, Crown E, Larsen L, Yu Y, Wedemeyer H. Lampertico P, et al. Among authors: cornberg m. J Hepatol. 2020 Jun;72(6):1112-1121. doi: 10.1016/j.jhep.2020.01.025. Epub 2020 Feb 13. J Hepatol. 2020. PMID: 32061651 Free article.

2

Current and future treatment of hepatitis C.

Manns MP, Cornberg M, Wedemeyer H. Manns MP, et al. Among authors: cornberg m. Indian J Gastroenterol. 2001 Mar;20 Suppl 1:C47-51. Indian J Gastroenterol. 2001. PMID: 11293180 Review.

3

[PEG-interferons: significance for the treatment of viral hepatitis B and C].

Wedemeyer H, Cornberg M, Manns MP. Wedemeyer H, et al. Among authors: cornberg m. Dtsch Med Wochenschr. 2001 Jun 1;126 Suppl 1:S68-75. doi: 10.1055/s-2001-14495. Dtsch Med Wochenschr. 2001. PMID: 11450618 Review. German. No abstract available.

4

Treatment of acute hepatitis C with interferon alfa-2b.

Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, Pastore G, Dietrich M, Trautwein C, Manns MP; German Acute Hepatitis C Therapy Group. Jaeckel E, et al. Among authors: cornberg m. N Engl J Med. 2001 Nov 15;345(20):1452-7. doi: 10.1056/NEJMoa011232. N Engl J Med. 2001. PMID: 11794193 Free article. Clinical Trial.

5

Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.

Cornberg M, Wedemeyer H, Manns MP. Cornberg M, et al. Curr Gastroenterol Rep. 2002 Feb;4(1):23-30. doi: 10.1007/s11894-002-0034-y. Curr Gastroenterol Rep. 2002. PMID: 11825538 Review.

6

Hepatitis C: therapeutic perspectives.

Cornberg M, Wedemeyer H, Manns MP. Cornberg M, et al. Forum (Genova). 2001 Apr-Jun;11(2):154-62. Forum (Genova). 2001. PMID: 11948360 Review.

7

Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C.

Cornberg M, Hinrichsen H, Teuber G, Berg T, Naumann U, Falkenberg C, Zeuzem S, Manns MP. Cornberg M, et al. J Hepatol. 2002 Dec;37(6):843-7. doi: 10.1016/s0168-8278(02)00300-8. J Hepatol. 2002. PMID: 12445427

8

Polyethylene glycol-interferon: current status in hepatitis C virus therapy.

Wedemeyer H, Wiegand J, Cornberg M, Manns MP. Wedemeyer H, et al. Among authors: cornberg m. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S344-50. doi: 10.1046/j.1440-1746.17.s3.26.x. J Gastroenterol Hepatol. 2002. PMID: 12472962 Review.

9

[Treatment of chronic hepatitis C with PEG-interferon alpha-2b and ribavirin: 24 weeks of therapy are sufficient for HCV genotype 2 and 3].

Cornberg M, Hüppe D, Wiegand J, Felten G, Wedemeyer H, Manns MP. Cornberg M, et al. Z Gastroenterol. 2003 Jun;41(6):517-22. doi: 10.1055/s-2003-39649. Z Gastroenterol. 2003. PMID: 12806536 German.

10

Isolated anti-HBV core phenotype in anti-HCV-positive patients is associated with hepatitis C virus replication.

Wedemeyer H, Cornberg M, Tegtmeyer B, Frank H, Tillmann HL, Manns MP. Wedemeyer H, et al. Among authors: cornberg m. Clin Microbiol Infect. 2004 Jan;10(1):70-2. doi: 10.1111/j.1469-0691.2004.00771.x. Clin Microbiol Infect. 2004. PMID: 14706089 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

415 results

Search Page

Filters